U.S. Markets open in 2 hrs 26 mins

AVEO Pharmaceuticals, Inc. (AVEO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.5600+0.1200 (+2.70%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.61
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.2000
52 Week Low 32.2300
50-Day Moving Average 34.7189
200-Day Moving Average 35.3537

Share Statistics

Avg Vol (3 month) 3765.28k
Avg Vol (10 day) 3331.07k
Shares Outstanding 525.81M
Float 11.74M
% Held by Insiders 10.25%
% Held by Institutions 127.01%
Shares Short (Jul 14, 2020) 41.39M
Short Ratio (Jul 14, 2020) 41.24
Short % of Float (Jul 14, 2020) 45.99%
Short % of Shares Outstanding (Jul 14, 2020) 45.38%
Shares Short (prior month Jun 14, 2020) 42.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Feb 19, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Mar 30, 2020


Profit Margin 1.62%
Operating Margin (ttm)-12.13%

Management Effectiveness

Return on Assets (ttm)-6.52%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)27.97M
Revenue Per Share (ttm)1.74
Quarterly Revenue Growth (yoy)-51.30%
Gross Profit (ttm)10.84M
Net Income Avi to Common (ttm)452k
Diluted EPS (ttm)0.0280
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)33.62M
Total Cash Per Share (mrq)2.09
Total Debt (mrq)14.52M
Total Debt/Equity (mrq)207.13
Current Ratio (mrq)1.68
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)-6.15M
Levered Free Cash Flow (ttm)-2.99M